
| Genencor International | |
| Type: | Subsidiary |
| Location: | Palo Alto, California, U.S. |
| Key People: | Tjerk de Ruiter (Chairman & CEO) |
| Industry: | Biotechnology |
| Products: | Purafect, Properase, Spezyme |
| Revenue: | (2005) |
| Num Employees: | 1,500 (2005) |
| Parent: | IFF |
Genencor is a biotechnology company based in Palo Alto, CA and a subsidiary of IFF.[1] Genencor is a producer of Industrial enzymes and low-priced bulk protein. It is considered to have pioneered the field of industrial biotechnology, as distinct from traditional applications of biotechnology to health care and agriculture.[2]
The name Genencor originates with Genencor, Inc., the original joint venture between Genentech and Corning Incorporated, which was founded in 1982. A.E. Staley made a substantial investment to the company in 1984, making it a partner with Corning and Genentech. After Eastman bought A.E. Staley's share, Genencor became part of Eastman Kodak.[3]
In 2005 Genencor was acquired by Danisco.
In 2008 Genencor entered a joint venture with DuPont, called DuPont Danisco Cellulosic Ethanol LLC, to develop and commercialize low cost technology for the production of cellulosic ethanol.[4] In 2008, Genencor and Goodyear announced they were working to develop BioIsoprene.
In 2011, DuPont acquired Danisco for $6.3 billion.[5]
In 2021, portions of DuPont including the Genencor division were acquired by International Flavors & Fragrances.[6]
Genencor achieved the following awards: